We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Bariatric Surgery Risk Greater Than Thought

By HospiMedica staff writers
Posted on 02 Nov 2005
A study of more than 16,000 patients 65 and over has shown that the risk of early death after bariatric surgery is considerably higher than previously suggested and may be associated with advancing age, male sex, and a low surgeon volume of procedures.

Bariatric surgery is the only intervention that consistently helps patients achieve and sustain weight loss and improvements in related medical conditions. More...
This has resulted in a dramatic growth in this type of surgery, as revealed in a second study of trends in bariatric surgery, led by Dr. Heena P. Santry, department of surgery at the University of Chicago (IL, USA). From 1998 to 2002, the number of elective procedures rose from 13,365 to 72,177. Meanwhile, the risks have been poorly defined. High-profile users whose procedures ended in death after the surgery have now sparked a critical reappraisal of the safety of bariatric surgery.

Lead author of the first study, David R. Flum, M.D., M.P.H., department of surgery, University of Washington (Seattle, USA), revealed that skepticism is warranted. Patients 65 and over in his study had a substantially higher risk of death within the early postoperative period than younger patients. Men had higher rates of early death than women, and the odds of death within 90 days were five-fold greater for patients over 75 than for those 65-74. Also, the odds of death at 90 days were 1.6 times higher for patients of surgeons with less than the median surgical volume of bariatric procedures.

"The risk of death is much higher than has been reported,” observed Dr. Flum.

A third study, by Dr. David Zingmond of the University of California at Los Angeles (USA), has shown that increases in hospital use appear to be related to the Roux-en-Y gastric bypass procedure. All three studies were published in the October 19, 2005, issue of the Journal of the American Medical Association.




Related Links:
University of Washington

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.